A unique mechanism for innate cytokine promotion of T cell responses to viral infections

Journal of Immunology

Volumn 169, Issue 10, 2002, Pages 5827-5837

  Pien, Gary C ^a   Nguyen, Khuong B ^a   Malmgaard, Lene ^a   Satoskar, Abhay R ^a   Biron, Christine A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; LIVER HOMOGENATE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN; T LYMPHOCYTE; VIRUS INFECTION; VIRUS MENINGITIS; VIRUS STRAIN;

EID: 0037111237     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.10.5827     Document Type: Article

References (74)

1. Lehmann-Grube, F., J. Cihak, M. Varho, and R. Tijerina. 1982. The immune response of the mouse to lymphocytic choriomeningitis virus. II. Active suppression of cell-mediated immunity by infection with high virus doses. J. Gen. Virol. 58:223.
2. Busch, D. H., and E. G. Pamer. 1999. T lymphocyte dynamics during Listeria monocytogenes infection. Immunol. Lett. 65:93.
3. Biron, C. A. 1998. Role of early cytokines, including α and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol. 10:383.
4. Pfeffer, L. M., C. A. Dinarello, R. B. Herberman, B. R. Williams, E. C. Borden, R. Bordens, M. R. Walter, T. L. Nagabhushan, P. P. Trotta, and S. Pestka. 1998. Biological properties of recombinant α-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58:2489.
5. Biron, C. A. 1999. Initial and innate responses to viral infections: Pattern setting in immunity or disease. Curr. Opin. Microbiol. 2:374.
6. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and T. P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
7. Biron, C. A. 2001. Interferons α and β as immune regulators: A new look. Immunity 14:661.
8. Riviere, Y., and M. T. Bandu. 1977. Induction d'interferon par le virus de la choriomenigite lymphocytaire chez la souris. Ann. Microbiol. 128A:323.
9. Orange, J. S., and C. A. Biron. 1996. Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746.
10. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J. Immunol. 156:1138.
11. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin 12 and interferon-γ production in vitro and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634.
12. Pien, G. C., and C. A. Biron. 2000. Compartmental differences in NK cell responsiveness to IL-12 during lymphocytic choriomeningitis virus infection. J. Immunol. 164:994.
13. Moskophidis, D., M. Battegay, M. A. Bruendler, E. Laine, I. Gresser, and R. M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to α/β interferon and to γ interferon. J. Virol. 68:1951.
14. Cousens, L. P., R. Peterson, S. Hsu, A. Dorner, J. D. Altman, R. Ahmed, and C. A. Biron. 1999. Two roads diverged: Interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection. J. Exp. Med. 189:1315.
15. Sareneva, T., S. Matikainen, M. Kurimoto, and I. Julkunen. 1998. Influenza A virus-induced IFN-αβ and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J. Immunol. 160:6032.
16. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanishi. 1998. Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281.
17. Dinarello, C. A. 1999. Interleukin-18. Methods 19:121.
18. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, et al. 1996. Interferon-γ-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-γ production. Eur. J. Immunol. 26:1647.
19. Ghayur, T., S. Banerjee, M. Hugunin, D. Butler, L. Herzog, A. Carter, L. Quintal, L. Sekut, R. Talanian, M. Paskind, et al. 1997. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386:619.
20. Hunter, C. A., J. Timans, P. Pisacane, S. Menon, G. Cai, W. Walker, M. Aste-Amezaga, R. Chizzonite, J. F, Bazan, and R. A, Kastelein. 1997. Comparison of the effects of interleukin-1α interleukin-1β, and interferon-γ-inducing factor on the production of interferon-γ by natural killer. Eur. J. Immunol. 27:2787.
21. Kohno, K., J. Kataoka, T. Ohtsuki, Y. Suemoto, I. Okamoto, M. Usui, M. Ikeda, and M. Kurimoto. 1997. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J. Immunol. 158:1541.
22. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity. 8:383.
23. Sayos, J., K. B. Nguyen, C. Wu, S. E. Stepp, D. Howie, J. D. Schatzle, V. Kumar, C. A. Biron, and C. Terhorst. 2000. Potential pathways for regulation of NK and T cell responses: Differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol. 12:1749.
24. Pien, G. C., A. R. Satoskar, K. Takeda, S. Akira, and C. A. Biron. 2000. Cutting edge: selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection. J. Immunol. 165:4787.
25. Gairin, J. E., and M. B. Oldstone. 1992. Design of high-affinity major histocompatibility complex-specific antagonist peptides that inhibit cytotoxic T-lymphocyte activity: Implications for control of viral disease. J. Virol. 66:6755.
26. von Herrath, M. G., B. Coon, H. Lewicki, H. Mazarguil, J. E. Gairin, and M. B. Oldstone. 1998. In vivo treatment with a MHC class 1-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J. Immunol. 161:5087.
27. Oldstone, M. B., M. Von Herrath, H. Lewicki, D. Hudrisier, J. L. Whitton, and J. E. Gairin. 1999. Use of a high-affinity peptide that aborts MHC-restricted cytotoxic T lymphocyte activity against multiple viruses in vitro and virus-induced immunopathologic disease in vivo. Virology 256:246.
28. Ishikawa, R., and C. A. Biron. 1993. IFN induction and associated changes in splenic leukocyte distribution. J. Immunol. 150:3713.
29. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
30. Oldstone, M. B., J. L. Whitton, H. Lewicki, and A. Tishon. 1988. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class 1-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168:559.
31. Schulz, M., P. Aichele, M. Vollenweider, F. W. Bobe, F. Cardinaux, H, Hengartner, and R. M. Zinkernagel. 1989. Major histocompatibility complex-dependent T cell epitopes of lymphocytic choriomeningitis virus nucleoprotein and their protective capacity against viral disease. Eur. J. Immunol. 19:1657.
32. Klavinskis, L. S., J. L. Whitton, E. Joly, and M. B. Oldstone. 1990. Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393.
33. b major histocompatibility complex class 1 molecules and presented to cytotoxic T lymphocytes. J. Virol. 69;2297.
34. b-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice. Virology 240:158.
35. Biron, C. A., R. J. Natuk, and R. M. Welsh. 1986. Generation of large granular T lymphocytes in vivo during viral infection. J. Immunol. 136:2280.
36. Leist, T. P., S. P. Cobbold, H. Waldmann, M. Aguet, and R. M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278.
37. + T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61:1867.
38. Gessner, A., D. Moskophidis, and F. Lehmann-Grube. 1989. Enumeration of single IFN-γ-producing cells in mice during viral and bacterial infection. J. Immunol. 142:1293.
39. + T cell interactions in IFN-γ and IL-4 responses to viral infections: Requirements for IL-2. J. Immunol. 160:5007.
40. Lehmann-Grube, F., U. Assmann, C. Loliger, D. Moskophidis, and J. Lohler. 1985. Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. J. Immunol. 134:608.
41. Cerny, A., S. Sutter, H. Bazin, H. Hengartner, and R. M. Zinkernagel. 1988. Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice. J. Virol. 62:1803.
42. Lehmann-Grube, F., D. Moskophidis, and J. Lohler. 1988. Recovery from acute virus infection: Role of cytotoxic T lymphocytes in the elimination of lymphocytic choriomeningitis virus from spleens of mice. Ann. NY Acad. Sci. 532:238.
43. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933.
44. + T cells during an acute virus infection. Immunity 8:167.
45. von Herrath, M. G., J. Dockter, M. Nerenberg, J. E. Gairin, and M. B. Oldstone. 1994. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J. Exp. Med. 180:1901.
46. van der Most, R. G., R. J. Concepcion, C. Oseroff, J. Alexander, S. Southwood, J. Sidney, R. W. Chesnut, R. Ahmed, and A. Sette. 1997. Uncovering subdominant cytotoxic T-lymphocyte responses in lymphocytic choriomeningitis virus-infected BALB/c mice. J. Virol. 71:5110.
47. von Herrath, M. G., B. Coon, and M. B. Oldstone. 1997. Low-affinity cytotoxic T-lymphocytes require IFN-γ to clear an acute viral infection. Virology 229:349.
48. von Herrath, M. G., and M. B. Oldstone. 1997. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531.
49. Yap, G., M. Pesin, and A. Sher. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol. 165:628.
50. Park, A. Y., B. D. Hondowicz, and P. Scott. 2000. IL-12 is required to maintain a Th1 response during Leishmania major infection. J. Immunol. 165:896.
51. Wong, P., and E. G. Pamer. 2001. Cutting edge: Antigen-independent cd8 T cell proliferation. J. Immunol. 166:5864.
52. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity. 7:571.
53. Penix, L. A., M. T. Sweetser, W. M. Weaver, J. P. Hoeffler, T. K. Kerppola, and C. B. Wilson. 1996. The proximal regulatory element of the interferon-γ promoter mediates selective expression in T cells. J. Biol. Chem. 271:31964.
54. Sweetser, M. T., T. Hoey, Y. L. Sun, W. M. Weaver, G. A. Price, and C. B. Wilson. 1998. The roles of nuclear factor of activated T cells and ying-yang 1 in activation-induced expression of the interferon-γ promoter in T cells. J. Biol. Chem. 273:34775.
55. + T cells: Evidence for two distinct pathways for promoter activation. Eur. J. Immunol. 29:548.
56. Yang, J., H. Zhu, T. L. Murphy, W. Ouyang, and K. M. Murphy. 2001. IL-18-stimulated GADD45 β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2:157.
57. + T cells. J. Exp. Med. 189:1355.
58. Pirhonen, J., T. Sareneva, I. Julkunen, and S. Matikainen. 2001. Virus infection induces proteolytic processing of IL-18 in human macrophages via caspase-1 and caspase-3 activation. Eur. J. Immunol. 31:726.
59. Sareneva, T., I. Julkunen, and S. Matikainen. 2000. IFN-α and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 165:1933.
60. Biron, C. A., and G. C. Sen. 2001. Interferons and other cytokines. In Fields Virology, 4th Ed. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott Williams & Wilkins, pp. 321-351.
61. Malmgaard, L., T. P. Salazar-Mather, C. A. Lewis, and C. A. Biron. 2002. Promotion of α/β interferon induction during in vivo viral infection through α/β interferon receptor/STAT1 system-dependent and -independent pathways. J. Virol. 76:4520.
62. Tripp, C. S., O. Kanagawa, and E. R. Unanue. 1995. Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12. J. Immunol. 155:3427.
63. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. Y. Denkers, S. Hieny, P. Caspar, G. Trinchieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
64. Orange, J. S., B. Wang, C. Terhorst, and C. A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalo-virus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045.
65. Utermohlen, O., A. Dangel, A. Tarnok, and F. Lehmann-Grube. 1996. Modulation by γ interferon of antiviral cell-mediated immune responses in vivo. J. Virol. 70:1521.
66. Leist, T. P., M. Eppler, and R. M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-γ interferontreated mice. J. Virol. 63:2813.
67. Bartholdy, C., J. P. Christensen, D. Wodarz, and A. R. Thomsen. 2000. Persistent virus infection despite chronic cytotoxic T-lymphocyte activation in γ interferon-deficient mice infection with lymphocytic choriomeningitis virus. J. Virol. 74:10304.
68. Sandberg, K., P. Kemper, A. Stalder, J, Zhang, M. V. Hobbs, J. L. Whitton, and I. L. Campbell. 1994. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-αβ. J. Immunol 153:220.
69. Nguyen, K. B., L. P. Cousens, L. A. Doughty, G. C. Pien, J. E. Durbin, and C. A. Biron. 2000. Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox. Nat. Immunol. 1:70.
70. Liu, Y., and C. A. Janeway, Jr. 1990. Interferon γ plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J. Exp. Med. 172:1735.
71. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Pluckthun, T. Elliott, H. Hengartner, and R. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes. J. Exp. Med. 187:1383.
72. Orange, J. S., S. F. Wolf, and C. A. Biron. 1994. Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152:1253.
73. Farrar, J. D., J. D. Smith, T. L. Murphy, S. Leung, G. R. Stark, and K. M. Murphy. 2000. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat. Immunol. 1:65.
74. Su, H. C., K. B. Nguyen, T. P. Salazar-Mather, M. C. Ruzek, M. Y. Dalod, and C. A. Biron. 2001. NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 31:3048.